Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Penumbra (PEN) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Penumbra (PEN) over the last 12 years, with Q3 2025 value amounting to $321.0 million.

  • Penumbra's Cash & Equivalents rose 1445.86% to $321.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $321.0 million, marking a year-over-year increase of 1445.86%. This contributed to the annual value of $324.4 million for FY2024, which is 9369.02% up from last year.
  • Per Penumbra's latest filing, its Cash & Equivalents stood at $321.0 million for Q3 2025, which was up 1445.86% from $421.8 million recorded in Q2 2025.
  • Penumbra's 5-year Cash & Equivalents high stood at $421.8 million for Q2 2025, and its period low was $54.8 million during Q3 2022.
  • Its 5-year average for Cash & Equivalents is $174.7 million, with a median of $107.5 million in 2023.
  • Per our database at Business Quant, Penumbra's Cash & Equivalents crashed by 2321.96% in 2021 and then surged by 17836.87% in 2024.
  • Over the past 5 years, Penumbra's Cash & Equivalents (Quarter) stood at $59.4 million in 2021, then grew by 17.65% to $69.9 million in 2022, then skyrocketed by 139.75% to $167.5 million in 2023, then skyrocketed by 93.69% to $324.4 million in 2024, then fell by 1.04% to $321.0 million in 2025.
  • Its Cash & Equivalents stands at $321.0 million for Q3 2025, versus $421.8 million for Q2 2025 and $376.1 million for Q1 2025.